Literature DB >> 25680424

Factors associated with bone mineral density in healthy African women.

Nyaradzo M Mgodi1, Cliff Kelly, Brenda Gati, Susan Greenspan, James Y Dai, Vivian Bragg, Edward Livant, Jeanna M Piper, Clemensia Nakabiito, Tsitsi Magure, Jeanne M Marrazzo, Z Mike Chirenje, Sharon A Riddler.   

Abstract

UNLABELLED: There is a paucity of normative bone mineral density (BMD) data in healthy African women. Baseline total hip and lumbar spine BMD was measured in premenopausal women. BMD distribution was comparable to that of a reference population and was impacted by several factors including contraception and duration of lactation.
INTRODUCTION: Normative data on bone mineral density (BMD) and the cumulative impact of lactation, contraceptive use, and other factors on BMD in healthy African women have not been well studied.
OBJECTIVES: The objective of this study was to determine the factors associated with BMD in healthy premenopausal women in Uganda and Zimbabwe.
METHODS: Baseline total hip (TH) and lumbar spine (LS) BMD was measured by dual x-ray absorptiometry in 518 healthy, premenopausal black women enrolling in VOICE, an HIV-1 chemoprevention trial, at sites in Uganda and Zimbabwe. Contraceptive and lactation histories, physical activity assessment, calcium intake, and serum vitamin D levels were assessed. Independent factors associated with BMD were identified using an analysis of covariance model.
RESULTS: The study enrolled 331 women from Zimbabwe and 187 women from Uganda. Median age was 29 years (IQR 25, 32) and median body mass index (BMI) was 24.8 kg/m(2) (IQR 22.2, 28.6). In univariate analyses, lower TH BMD values were associated with residence in Uganda (p < 0.001), lower BMI (p < 0.001), and any use of and duration of depot-medroxyprogresterone acetate. Use of oral contraceptives, progestin-only implants, and higher physical activity levels were protective against reduced BMD. Similarly, lower LS BMD values were associated with these same factors but also higher parity and history of breastfeeding. In a multivariable analysis, lower TH and LS BMD values were associated with enrollment in Uganda, lower BMI, and lower physical activity level; contraceptive use was associated with lower spine BMD, and breastfeeding contributed to lower total hip BMD.
CONCLUSIONS: Among healthy premenopausal women, TH and LS BMD was higher in Zimbabwe than Uganda. Additional factors independently associated with BMD included BMI, physical activity level, contraceptive use, and lactation.

Entities:  

Mesh:

Year:  2015        PMID: 25680424      PMCID: PMC4564062          DOI: 10.1007/s11657-015-0206-7

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  26 in total

1.  Family planning in sub-Saharan Africa: progress or stagnation?

Authors:  John G Cleland; Robert P Ndugwa; Eliya M Zulu
Journal:  Bull World Health Organ       Date:  2010-11-04       Impact factor: 9.408

2.  Site-specific differences in bone mineral density in black and white premenopausal South African women.

Authors:  S Chantler; K Dickie; J H Goedecke; N S Levitt; E V Lambert; J Evans; Y Joffe; L K Micklesfield
Journal:  Osteoporos Int       Date:  2011-03-03       Impact factor: 4.507

3.  Pregnancy and lactation confer reversible bone loss in humans.

Authors:  C Karlsson; K J Obrant; M Karlsson
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

4.  Effects of levonorgestrel-releasing subdermal contraceptive implants on bone density and bone metabolism.

Authors:  X Di; Y Li; C Zhang; J Jiang; S Gu
Journal:  Contraception       Date:  1999-09       Impact factor: 3.375

Review 5.  Overview of the relationship between use of progestogen-only contraceptives and bone mineral density.

Authors:  E Banks; A Berrington; D Casabonne
Journal:  BJOG       Date:  2001-12       Impact factor: 6.531

6.  Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population. The WHO Study of Hormonal Contraception and Bone Health.

Authors:  D B Petitti; G Piaggio; S Mehta; M C Cravioto; O Meirik
Journal:  Obstet Gynecol       Date:  2000-05       Impact factor: 7.661

7.  Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception.

Authors:  R Beerthuizen; A van Beek; R Massai; L Mäkäräinen; J Hout; H C Bennink
Journal:  Hum Reprod       Date:  2000-01       Impact factor: 6.918

8.  Tenofovir-based preexposure prophylaxis for HIV infection among African women.

Authors:  Jeanne M Marrazzo; Gita Ramjee; Barbra A Richardson; Kailazarid Gomez; Nyaradzo Mgodi; Gonasagrie Nair; Thesla Palanee; Clemensia Nakabiito; Ariane van der Straten; Lisa Noguchi; Craig W Hendrix; James Y Dai; Shayhana Ganesh; Baningi Mkhize; Marthinette Taljaard; Urvi M Parikh; Jeanna Piper; Benoît Mâsse; Cynthia Grossman; James Rooney; Jill L Schwartz; Heather Watts; Mark A Marzinke; Sharon L Hillier; Ian M McGowan; Z Mike Chirenje
Journal:  N Engl J Med       Date:  2015-02-05       Impact factor: 91.245

9.  Ethnic variation in bone density in premenopausal and early perimenopausal women: effects of anthropometric and lifestyle factors.

Authors:  Joel S Finkelstein; Mei-Ling T Lee; MaryFran Sowers; Bruce Ettinger; Robert M Neer; Jennifer L Kelsey; Jane A Cauley; Mei-Hua Huang; Gail A Greendale
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

10.  Bone mineral density changes among HIV-uninfected young adults in a randomised trial of pre-exposure prophylaxis with tenofovir-emtricitabine or placebo in Botswana.

Authors:  Michael Kasonde; Richard W Niska; Charles Rose; Faith L Henderson; Tebogo M Segolodi; Kyle Turner; Dawn K Smith; Michael C Thigpen; Lynn A Paxton
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

View more
  6 in total

1.  Peripartum dietary supplementation of a small-molecule inhibitor of tryptophan hydroxylase 1 compromises infant, but not maternal, bone.

Authors:  Samantha R Weaver; Hannah P Fricke; Cynthia Xie; Robert J Aiello; Julia F Charles; Laura L Hernandez
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-10-23       Impact factor: 4.310

Review 2.  Could use of Selective Serotonin Reuptake Inhibitors During Lactation Cause Persistent Effects on Maternal Bone?

Authors:  Samantha R Weaver; Laura L Hernandez
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-03-30       Impact factor: 2.673

3.  Peripartum Fluoxetine Reduces Maternal Trabecular Bone After Weaning and Elevates Mammary Gland Serotonin and PTHrP.

Authors:  Samantha R Weaver; Hannah P Fricke; Cynthia Xie; Robert J Lipinski; Chad M Vezina; Julia F Charles; Laura L Hernandez
Journal:  Endocrinology       Date:  2018-08-01       Impact factor: 4.736

4.  Bone Mineral Density Changes Among Young, Healthy African Women Receiving Oral Tenofovir for HIV Preexposure Prophylaxis.

Authors:  Brenda G Mirembe; Clifton W Kelly; Nyaradzo Mgodi; Susan Greenspan; James Y Dai; Ashley Mayo; Jeanna Piper; Carolyne A Akello; Flavia M Kiweewa; Tsitsi Magure; Clemensia Nakabiito; Jeanne M Marrazzo; Z Mike Chirenje; Sharon A Riddler
Journal:  J Acquir Immune Defic Syndr       Date:  2016-03-01       Impact factor: 3.731

5.  Peripartal treatment with low-dose sertraline accelerates mammary gland involution and has minimal effects on maternal and offspring bone.

Authors:  Celeste M Sheftel; Luma C Sartori; Emily R Hunt; Robbie S J Manuel; Autumn M Bell; Rafael R Domingues; Lella A Wake; Brandon R Scharpf; Chad M Vezina; Julia F Charles; Laura L Hernandez
Journal:  Physiol Rep       Date:  2022-03

6.  Calcium deficiency worldwide: prevalence of inadequate intakes and associated health outcomes.

Authors:  Julie Shlisky; Rubina Mandlik; Sufia Askari; Steven Abrams; Jose M Belizan; Megan W Bourassa; Gabriela Cormick; Amalia Driller-Colangelo; Filomena Gomes; Anuradha Khadilkar; Victor Owino; John M Pettifor; Ziaul H Rana; Daniel E Roth; Connie Weaver
Journal:  Ann N Y Acad Sci       Date:  2022-03-05       Impact factor: 6.499

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.